IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. 

Biotechnology

IO Biotech

Mai-Britt Zocca

Misbah Sherwani

Qasim Ahmad

Devin Smith

Eric Faulkner

Amy Sullivan

Brian Burkavage

Ayako Wakatsuki Pedersen

Margaret Siemon-Hryczyk

Dan Mannix

Diane Mcdowell

Muhammad Al-Hajj

Research and Development

Regulatory and Clinical Operations

Clinical Operations Team

Finance and Accounting

Leadership Team

Teams at IO Biotech

Research and Development

Regulatory and Clinical Operations

Clinical Operations Team

Finance and Accounting

Leadership Team